Last update:

Oncology & Cancer news

Oncology & Cancer

Microbial patterns in colorectal tumors may predict patient survival and disease progression

A recent study shows that bacteria living inside colorectal tumors form distinct ecosystems that are closely linked to how the disease progresses and patient outcomes. These "tissue-resident" microbes appear to play an integral ...

Oncology & Cancer

Study links dozens of blood proteins to prostate cancer risk across populations

A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, some unique to specific groups.

Oncology & Cancer

In-surgery radiation cuts pancreatic cancer return

Using targeted radiation during surgery—referred to as intraoperative radiation—to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce ...

Oncology & Cancer

AI tool identifies women at high risk of interval breast cancer

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Oncology & Cancer

Scientists uncover new driver of ovarian cancer spread

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly improve the outlook for women diagnosed with this aggressive disease.

Oncology & Cancer

Why fasting won't cleanse your body—or beat cancer

Every few months, a new "miracle cure" for cancer trends on social media. From superfoods and supplements to extreme diets, the promises are always bold—and almost always misleading. The latest claim suggests that a 21-day ...

Oncology & Cancer

Living tumor-on-a-chip exposes how cancers block immune attacks

For a little over two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a powerful new way to treat cancer. By extracting patients' T cells, re-engineering them to recognize tumor antigens, and infusing ...